1. Mutator phenotypes in human colorectal carcinoma cell lines.
2. Boyer JC, Umar A, Risinger JI, et al. Microsatellite instability, mismatch repair deficiency, and genetic defects in human cancer cell lines. Cancer Res. 1995. 55: 6063-6070.
3. Disruption of p53 in human cancer cells alters the responses to therapeutic agents
4. Capizzi RL. Clinical status and optimal use of amifostine. Oncology. 1999. 13: 47-59.
5. Capizzi RL, Oster W. Chemoprotective and radioprotective effects of amifostine: an update of clinical trials. Int J Hematol. 2000. 72: 425-435.